Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Idenix Pharmaceuticals logo — Pioneering advancements in antiviral therapies, focused on c...

Idenix Pharmaceuticals

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a strong presence in the U.S. and Europe.

Founded 1998 Post Ipo Equity Total: $155.00M Biotechnology, Health Care

General Information

Company Name Idenix Pharmaceuticals
Founded Year 1998
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Idenix Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Idenix Pharmaceuticals

Idenix Pharmaceuticals is a biopharmaceutical company founded in 1998 that focuses on developing antiviral therapies for diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus type I (HIV), and acquired immune deficiency syndrome (AIDS). The company achieved a significant milestone in July 2009 by completing a proof-of-concept clinical trial for treatment-naive HCV genotype I infected patients. Shortly after, in October 2009, Idenix initiated a 14-day dose-ranging phase IIa clinical trial to evaluate IDX184 in combination with pegylated interferon and ribavirin for the same patient group. Additionally, IDX320 was chosen as the lead clinical candidate from its protease inhibitor discovery program. The company's research and development operations are based in the United States and Europe. Their last investment, totaling $107.00M, was received as a Post-IPO equity investment on 28th January 2014 from The Baupost Group. With a strong presence in the U.S. and Europe, Idenix Pharmaceuticals is pioneering advancements in antiviral therapies, cementing its position in the Biotechnology and Health Care industries.

Taxonomy: biopharmaceutical company, drug discovery, antiviral therapies, HCV treatment, hepatitis C virus, HBV treatment, HIV treatment, AIDS treatment, clinical trials, drug development, protease inhibitors, proof-of-concept trials, pegylated interferon, ribavirin, viral diseases

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1 •••• •••• 28 Jan 2014
Post-IPO Equity •••••• - 25 Apr 2011
Post-IPO Equity •••••• 1 •••• •••• 23 Nov 2010
Post-IPO Equity •••••• - 01 Aug 2009
Venture Round •••••• 1 •••• •••• 01 Jan 2003

Idenix Pharmaceuticals Alternatives & Competitors

Idenix Pharmaceuticals vs
Genelabs Technologies
Genelabs Technologies

Genelabs is a biopharmaceutical company focused on the discovery and development of novel compounds...

Series Unknown
24 employees
Biopharma, Biotechnology
Idenix Pharmaceuticals vs
Alphyn Biologics, Inc.
Alphyn Biologics, Inc. United States

Alphyn develops first-in-class, multi-target therapeutics for atopic dermatitis & other severe and c...

Series Unknown
4 employees
Health Care, Health and Wellness
Idenix Pharmaceuticals vs
Idun Pharmaceuticals
Idun Pharmaceuticals

Pioneering therapeutic solutions to control apoptosis and advance treatments for liver disease, CNS...

Debt Financing
2 employees
Biopharma, Biotechnology

FAQ About Idenix Pharmaceuticals

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a strong presence in the U.S. and Europe.
Idenix Pharmaceuticals was founded in 1998.
Idenix Pharmaceuticals operates in the following industries: Biotechnology, Health Care.
Idenix Pharmaceuticals has completed 5 funding rounds, raising a total of $155.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Idenix Pharmaceuticals include Genelabs Technologies, Alphyn Biologics, Inc., Idun Pharmaceuticals, Enterome, MindBio Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Idenix Pharmaceuticals and Genelabs Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Idenix Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy